Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2C19 polymorphisms and clopidogrel response in healthy volunteers
2006-004632-69Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel and lansoprazole (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Platelet aggregation induced by ADP 10 µM. Started Oct 2006; status: completed.
02
Drugs
clopidogrellansoprazole
Beyond the preview
Go deeper on 2006-004632-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004632-69.